Cumberland Pharmaceuticals Company Profile (NASDAQ:CPIX)

About Cumberland Pharmaceuticals

Cumberland Pharmaceuticals logoCumberland Pharmaceuticals Inc. (Cumberland) is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription products. The Company operates through specialty pharmaceutical products segment. The Company's product portfolio includes Acetadote (acetylcysteine) Injection for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) Injection for the treatment of pain and fever; Kristalose (lactulose) for Oral Solution for the treatment of chronic and acute constipation; Omeclamox-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease; Vaprisol (conivaptan) Injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Hepatoren (ifetroban) Injection, and Boxaban (ifetroban) oral capsules for the treatment of patients with aspirin-exacerbated respiratory disease (AERD).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: CPIX
  • CUSIP: 23077010
Key Metrics:
  • Previous Close: $5.71
  • 50 Day Moving Average: $5.97
  • 200 Day Moving Average: $5.24
  • 52-Week Range: $4.20 - $6.73
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 63.44
  • P/E Growth: 0.00
  • Market Cap: $92.39M
  • Outstanding Shares: 16,180,000
  • Beta: 1.36
Profitability:
  • Net Margins: -0.14%
  • Return on Equity: 1.46%
  • Return on Assets: 1.22%
Debt:
  • Debt-to-Equity Ratio: 0.05%
  • Current Ratio: 5.73%
  • Quick Ratio: 5.31%
Additional Links:
Companies Related to Cumberland Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Cumberland Pharmaceuticals (NASDAQ:CPIX) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Cumberland Pharmaceuticals (NASDAQ:CPIX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/1/2017        
5/10/2016Q116$0.02$8.70 million$7.70 millionViewListenView Earnings Details
3/3/2016Q415$0.03$29.93 million$8.04 millionViewN/AView Earnings Details
11/3/2015Q315$0.04$29.93 million$7.90 millionViewN/AView Earnings Details
8/4/2015Q215$0.09$29.93 million$8.90 millionViewN/AView Earnings Details
5/7/2015Q115$0.09$8.10 million$8.70 millionViewN/AView Earnings Details
3/3/2015Q414$0.10$8.05 million$9.30 millionViewN/AView Earnings Details
5/13/2014Q114$0.02$10.26 million$8.09 millionViewN/AView Earnings Details
3/4/2014Q4 13$0.05($0.08)ViewN/AView Earnings Details
11/5/2013Q313($0.04)$7.60 million$6.50 millionViewN/AView Earnings Details
8/6/2013Q2 2013$0.02($0.03)$9.40 million$7.10 millionViewN/AView Earnings Details
5/2/2013Q113$0.05$0.05$10.00 million$10.30 millionViewN/AView Earnings Details
2/28/2013Q4 2012$0.14$0.09$13.87 million$13.70 millionViewN/AView Earnings Details
11/1/2012Q312$0.09$0.10$13.05 million$12.50 millionViewN/AView Earnings Details
8/2/2012$0.07$0.09ViewN/AView Earnings Details
5/3/2012$0.05$0.02ViewN/AView Earnings Details
2/29/2012$0.05$0.04ViewN/AView Earnings Details
11/3/2011$0.06$0.09ViewN/AView Earnings Details
8/4/2011$0.04$0.11ViewN/AView Earnings Details
5/5/2011$0.03$0.03ViewN/AView Earnings Details
3/8/2011$0.03$0.04ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Current Year EPS Consensus Estimate: $0.09 EPS
Next Year EPS Consensus Estimate: $0.09 EPS

Dividends

Dividend History for Cumberland Pharmaceuticals (NASDAQ:CPIX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Insider Ownership Percentage: 37.00%
Institutional Ownership Percentage: 34.17%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/17/2016Michael BonnerCFOBuy900$5.50$4,950.00View SEC Filing  
8/17/2016Thomas R LawrenceDirectorSell3,000$4.60$13,800.00View SEC Filing  
5/26/2016Thomas R LawrenceDirectorSell3,000$4.55$13,650.00View SEC Filing  
11/19/2015Thomas R LawrenceDirectorSell4,000$5.61$22,440.00View SEC Filing  
3/19/2015Thomas R LawrenceDirectorSell6,000$6.95$41,700.00View SEC Filing  
11/20/2014Thomas R LawrenceDirectorSell10,000$5.12$51,200.00View SEC Filing  
8/21/2014Thomas R LawrenceDirectorSell15,000$5.08$76,200.00View SEC Filing  
3/19/2014Thomas LawrenceDirectorSell20,000$4.54$90,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Cumberland Pharmaceuticals (NASDAQ:CPIX)
DateHeadline
prnewswire.com logoCaldolor® Pediatric Fever Study Published Supporting Its Efficacy, Safety And Pharmacokinetics (NASDAQ:CPIX)
www.prnewswire.com - February 7 at 5:35 PM
prnewswire.com logoCaldolor® Pediatric Fever Study Published Supporting Its Efficacy, Safety And Pharmacokinetics (NASDAQ:CPIX)
www.prnewswire.com - February 7 at 5:35 PM
us.rd.yahoo.com logoU.S. Court Of Appeals Affirms Cumberland Pharmaceuticals' Victory In Patent Litigation Case (NASDAQ:CPIX)
us.rd.yahoo.com - January 30 at 5:19 PM
us.rd.yahoo.com logo8:17 am Cumberland Pharma announces the U.S. Court of Appeals for the Federal Circuit ruled in favor of Cumberland in a patent case associated with its Acetadote product, rejecting Mylan's (MYL (NASDAQ:CPIX)
us.rd.yahoo.com - January 30 at 5:19 PM
finance.yahoo.com logoCumberland Pharmaceuticals Announces Kenneth J. Krogulski To Join Its Board Of Directors (NASDAQ:CPIX)
finance.yahoo.com - January 16 at 10:28 AM
biz.yahoo.com logoCUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Other Events (NASDAQ:CPIX)
biz.yahoo.com - January 13 at 5:11 PM
News IconCumberland Pharmaceuticals Inc CPIX Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:CPIX)
www.bioportfolio.com - January 10 at 3:38 AM
proactiveinvestors.co.uk logoClinigen and partner to launch oncology support drug in US (NASDAQ:CPIX)
www.proactiveinvestors.co.uk - January 9 at 10:38 PM
streetinsider.com logoCumberland Pharmaceuticals (CPIX), Clinigen Enter Pact for Commercialization of Totect (NASDAQ:CPIX)
www.streetinsider.com - January 9 at 10:37 PM
finance.yahoo.com logo9:31 am Cumberland Pharma and and Clinigen Group plc announce an exclusive agreement to commercialize the oncology support drug Totect (dexrazoxane hydrochloride) in the U.S. (NASDAQ:CPIX)
finance.yahoo.com - January 9 at 5:37 PM
publicnow.com logoCumberland Emerging Technologies Appoints New Senior Executive (NASDAQ:CPIX)
www.publicnow.com - January 4 at 5:30 PM
capitalcube.com logoETFs with exposure to Cumberland Pharmaceuticals, Inc. : December 21, 2016 (NASDAQ:CPIX)
www.capitalcube.com - December 21 at 5:11 PM
News IconScleroderma Diagnostics and Therapeutics Market: Global Industry Analysis, Current and Future Trends by 2024 (NASDAQ:CPIX)
www.medgadget.com - December 8 at 9:20 PM
finance.yahoo.com logoBlog Coverage Cumberland Pharma Bags Exclusive Rights for Europe Based Nordic Group Injectable Methotrexate Product Line for the US Market (NASDAQ:CPIX)
finance.yahoo.com - November 17 at 10:16 AM
publicnow.com logoCumberland Pharmaceuticals Acquires U.S. Rights to Nordic Group's Methotrexate Injection Products (NASDAQ:CPIX)
www.publicnow.com - November 16 at 8:47 AM
capitalcube.com logoETF’s with exposure to Cumberland Pharmaceuticals, Inc. : November 4, 2016 (NASDAQ:CPIX)
www.capitalcube.com - November 4 at 1:53 PM
capitalcube.com logoCumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 3, 2016 (NASDAQ:CPIX)
www.capitalcube.com - November 3 at 3:51 PM
finance.yahoo.com logoEdited Transcript of CPIX earnings conference call or presentation 1-Nov-16 8:30pm GMT (NASDAQ:CPIX)
finance.yahoo.com - November 2 at 4:27 PM
sg.finance.yahoo.com logoCumberland posts 3Q profit (NASDAQ:CPIX)
sg.finance.yahoo.com - November 1 at 9:49 PM
biz.yahoo.com logoQ3 2016 Cumberland Pharmaceuticals Inc Earnings Release - After Market Close (NASDAQ:CPIX)
biz.yahoo.com - November 1 at 8:33 AM
finance.yahoo.com logoCumberland Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com November 3 (NASDAQ:CPIX)
finance.yahoo.com - October 28 at 4:04 PM
publicnow.com logoCumberland Pharmaceuticals To Announce Third Quarter 2016 Financial Results (NASDAQ:CPIX)
www.publicnow.com - October 25 at 4:26 PM
capitalcube.com logoETF’s with exposure to Cumberland Pharmaceuticals, Inc. : October 18, 2016 (NASDAQ:CPIX)
www.capitalcube.com - October 18 at 4:17 PM
feeds.reuters.com logoBRIEF-Clinigen and Cumberland Pharmaceuticals launch dry mouth drug in U.S (NASDAQ:CPIX)
feeds.reuters.com - September 26 at 9:07 AM
4-traders.com logoCumberland Pharmaceuticals : Announces New Program To Develop Portaban™ For Portal Hypertension (NASDAQ:CPIX)
www.4-traders.com - September 14 at 9:35 PM
feeds.reuters.com logoBRIEF-Cumberland reports new program to develop Portaban for Portal Hypertension (NASDAQ:CPIX)
feeds.reuters.com - September 14 at 4:54 PM
publicnow.com logoCumberland Pharmaceuticals Announces New Program To Develop Portaban™ For Portal Hypertension (NASDAQ:CPIX)
www.publicnow.com - September 14 at 4:25 PM
capitalcube.com logoETF’s with exposure to Cumberland Pharmaceuticals, Inc. : September 8, 2016 (NASDAQ:CPIX)
www.capitalcube.com - September 8 at 4:12 PM
streetinsider.com logoCumberland Pharmaceuticals (CPIX) Commences Shipments of Ethyol to U.S. Wholesalers (NASDAQ:CPIX)
www.streetinsider.com - August 24 at 9:37 AM
News IconDirector of Cumberland Pharmaceuticals Inc (NASDAQ:CPIX), Lawrence Thomas R, sells 3,000 shares worth $13,800 (NASDAQ:CPIX)
empowerednews.net - August 20 at 4:24 PM
live-pr.com logoNew Study: Cumberland Pharmaceuticals, Inc. (CPIX) - Financial and Strategic SWOT Analysis Review (NASDAQ:CPIX)
www.live-pr.com - August 19 at 3:28 PM
capitalcube.com logoETF’s with exposure to Cumberland Pharmaceuticals, Inc. : August 11, 2016 (NASDAQ:CPIX)
www.capitalcube.com - August 11 at 4:28 PM
capitalcube.com logoCumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 (NASDAQ:CPIX)
www.capitalcube.com - August 9 at 5:23 PM
sg.finance.yahoo.com logoCumberland posts 2Q loss (NASDAQ:CPIX)
sg.finance.yahoo.com - August 2 at 9:56 PM
publicnow.com logoCumberland Pharmaceuticals Reports Second Quarter 2016 Financial Results (NASDAQ:CPIX)
www.publicnow.com - August 2 at 4:29 PM
biz.yahoo.com logoQ2 2016 Cumberland Pharmaceuticals Inc Earnings Release - After Market Close (NASDAQ:CPIX)
biz.yahoo.com - August 2 at 9:12 AM
publicnow.com logoCumberland Pharmaceuticals To Announce Second Quarter 2016 Financial Results (NASDAQ:CPIX)
www.publicnow.com - July 26 at 4:18 PM
capitalcube.com logoETF’s with exposure to Cumberland Pharmaceuticals, Inc. : July 20, 2016 (NASDAQ:CPIX)
www.capitalcube.com - July 20 at 12:17 PM
fidaily.com logoShares Trading unchanged at $4.65 Cumberland Pharmaceuticals To… (NASDAQ:CPIX)
www.fidaily.com - July 19 at 10:36 AM
finance.yahoo.com logoCumberland Pharmaceuticals To Participate In Avondale Partners' 4th Annual Healthcare Conference (NASDAQ:CPIX)
finance.yahoo.com - July 18 at 9:00 AM
publicnow.com logoCumberland Pharmaceuticals Announces Caroline Young To Join Its Board Of Directors (NASDAQ:CPIX)
www.publicnow.com - June 10 at 8:19 AM
News IconLawrence Thomas R, Director of Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) sells 3,000 shares (NASDAQ:CPIX)
empowerednews.net - May 28 at 6:57 AM
capitalcube.com logoCumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:CPIX)
www.capitalcube.com - May 17 at 2:21 PM
biz.yahoo.com logoCUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition (NASDAQ:CPIX)
biz.yahoo.com - May 13 at 4:59 PM
finance.yahoo.com logoEdited Transcript of CPIX earnings conference call or presentation 10-May-16 8:30pm GMT (NASDAQ:CPIX)
finance.yahoo.com - May 10 at 6:33 PM
sg.finance.yahoo.com logoCumberland reports 1Q loss (NASDAQ:CPIX)
sg.finance.yahoo.com - May 10 at 5:36 PM
publicnow.com logoCumberland Pharmaceuticals Reports First Quarter 2016 Financial Results (NASDAQ:CPIX)
www.publicnow.com - May 10 at 4:18 PM
biz.yahoo.com logoQ1 2016 Cumberland Pharmaceuticals Inc Earnings Release - After Market Close (NASDAQ:CPIX)
biz.yahoo.com - May 10 at 7:07 AM
publicnow.com logoCumberland Pharmaceuticals To Announce First Quarter 2016 Financial Results (NASDAQ:CPIX)
www.publicnow.com - May 3 at 4:40 PM
News IconCumberland Pharmaceuticals Inc (CPIX): Ariel Investments Snapping Up Shares (NASDAQ:CPIX)
feedproxy.google.com - April 8 at 10:41 AM

Social

What is Cumberland Pharmaceuticals' stock symbol?

Cumberland Pharmaceuticals trades on the NASDAQ under the ticker symbol "CPIX."

When will Cumberland Pharmaceuticals announce their earnings?

Cumberland Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Wednesday, March, 1st 2017.

Who owns Cumberland Pharmaceuticals stock?

Cumberland Pharmaceuticals' stock is owned by many different of institutional and retail investors. Top institutional investors include Dimensional Fund Advisors LP (5.27%), Stonepine Capital Management LLC (3.83%), Renaissance Technologies LLC (1.59%), Bard Associates Inc. (0.57%) and United Capital Financial Advisers LLC (0.23%). Company insiders that own Cumberland Pharmaceuticals stock include Michael Bonner and Thomas R Lawrence.

Who sold Cumberland Pharmaceuticals stock? Who is selling Cumberland Pharmaceuticals stock?

Cumberland Pharmaceuticals' stock was sold by a variety of institutional investors in the last quarter, including United Capital Financial Advisers LLC and Bard Associates Inc..

Who bought Cumberland Pharmaceuticals stock? Who is buying Cumberland Pharmaceuticals stock?

Cumberland Pharmaceuticals' stock was acquired by a variety of institutional investors in the last quarter, including Stonepine Capital Management LLC, Renaissance Technologies LLC and Dimensional Fund Advisors LP.

How do I buy Cumberland Pharmaceuticals stock?

Shares of Cumberland Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Cumberland Pharmaceuticals stock cost?

One share of Cumberland Pharmaceuticals stock can currently be purchased for approximately $5.71.

Cumberland Pharmaceuticals (NASDAQ:CPIX) Chart for Monday, February, 20, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Cumberland Pharmaceuticals (NASDAQ:CPIX)

Earnings History Chart

Earnings by Quarter for Cumberland Pharmaceuticals (NASDAQ:CPIX)

Dividend History Chart

Dividend Payments by Quarter for Cumberland Pharmaceuticals (NASDAQ:CPIX)

Last Updated on 2/20/2017 by MarketBeat.com Staff